Skip to main content

CVS

  • CVS Pharmacy veteran Cheryl Mahoney dies

    CVS Pharmacy credited Cheryl Mahoney with helping it lead the market in both beauty sales and market share as vice president of beauty and personal care,
  • 6 top retailers make Fortune’s Most Admired list

    Key companies on the list, in descending order, were Amazon (3), Costco (12), were CVS Health (27), and Target (39), Walmart (42) and Publix (49).
  • CVS Health adds rheumatoid arthritis to Transform Care offerings

    In a move aimed at helping its pharmacy benefits management clients control high specialty drug costs and improve patient outcomes, CVS Health has introduced the Transform Rheumatoid Arthritis Care program.
  • Industry Issues Summit: Charting a roadmap for patient-facing care

    There’s no single magic bullet for enabling patient-facing care in community-based pharmacy, but there are proven strategies to make substantial progress.

  • Enabling patient-facing care: Pharmacists at the top of their licenses

    Pharmacists still are waiting for the handcuffs to come off. That’s the consensus of industry leaders who are frustrated with the challenges of getting reimbursements for a wider range of services these professionals can perform. It’s a topic at the center of enabling patient care in community-based pharmacy.

    “We talk about pharmacists being able to practice at the top of their license,” said CVS Health executive vice president of retail pharmacy and supply chain Kevin Hourican.

  • CVS Health offers 2018 outlook

    As it forges ahead with its proposed acquisition of Aetna, CVS Health on Thursday shared guidance for its 2018, during which it said it expects its operating profit rise between 1% and 4%. For the retail/long-term-care area of the business, the Woonsocket, R.I.-based company said that it expects low single-digit growth, with expected low- to mid-single-digit growth in the pharmacy services segment.

  • McKesson closes RxCrossroads deal

    McKesson on Wednesday completed its previously announced acquisition of RxCrossroads. RxCrossroads has become a part of the company’s McKesson Specialty Health business.

    According to the wholesaler, the acquisition is expected to enhance McKesson’s existing commercialization solutions for manufacturers of branded, specialty, generic and biosimilar drugs, including comprehensive patient support (“hub”) services, custom pharmacy solutions and third-party logistics, allowing McKesson to grow its end-to-end offerings for manufacturers.

X
This ad will auto-close in 10 seconds